文献速递消化、代谢与肾脏急症重症综合管理与镇静镇痛

通过「更明智的弗吉尼亚照护」倡议减少低价值照护

Reducing Low-Value Care Through the Smarter Care Virginia Initiative.
PubMed 文献 · JAMA Intern Med · 2026-11-09
一句话结论全州临床医生主导的多方倡议与低价值服务小幅减少相关(10.4%更少患者接受至少1项低价值服务,绝对减少-1.1个百分点),未观察到伤害证据。

该质量改进研究采用双重差分分析,比较弗吉尼亚州6个参与健康系统与12个对照系统中归因患者低价值服务的变化,干预前为2019年1月1日至12月31日,干预后为2022年1月1日至12月31日。干预「更明智的弗吉尼亚照护」包括健康系统财务支持、临床医生教育和季度同行比较绩效记分卡。2019年干预组10.5%、对照组10.7%的患者接受至少1项低价值服务;2021至2022年分别降至8.5%和9.1%。干预与接受至少1项低价值服务的患者减少10.4%相关(绝对减少-1.1个百分点,95%CI -2.1至-0.1个百分点,P=0.04);不良事件(0.03%;95%CI -0.02%至0.03%;P=0.84)和9项低价值服务人均支出(0.33美元;95%CI -3.43至4.11美元)无统计学显著变化。

要点

  • 全州临床医生主导倡议与接受至少1项低价值服务的患者减少10.4%相关(绝对减少-1.1个百分点,95%CI -2.1至-0.1个百分点,P=0.04)。
  • 干预组低价值服务接受率从2019年10.5%降至2021至2022年8.5%,对照组从10.7%降至9.1%。
  • 不良事件变化无统计学显著差异(0.03%;95%CI -0.02%至0.03%;P=0.84)。
  • 9项低价值服务人均支出变化无统计学显著差异(0.33美元;95%CI -3.43至4.11美元)。
  • 作者认为,实现更大降幅可能需要将此类健康系统驱动措施与支付改革、医生和医院问责等额外策略结合。

适用人群与场景

  • 弗吉尼亚州18个健康系统(6个干预系统、12个对照系统)中归因的、有资格接受9项低价值服务中至少1项的患者。

处置流程与药物剂量

  • 干预「更明智的弗吉尼亚照护」包含健康系统财务支持、临床医生教育和季度同行比较绩效记分卡。

研究设计与关键结果

  • 研究类型为质量改进研究,采用双重差分分析,比较6个干预健康系统与12个对照系统在2019年1月1日至12月31日(干预前)与2022年1月1日至12月31日(干预后)的低价值服务变化。
  • 主要终点:2019年干预组10.5%、对照组10.7%的患者接受至少1项低价值服务;2021至2022年分别降至8.5%和9.1%;干预与接受至少1项低价值服务的患者减少10.4%相关(绝对减少-1.1个百分点;95%CI -2.1至-0.1个百分点;P=0.04)。
  • 不良事件(如心肌梗死相关住院)变化无统计学显著差异(0.03%;95%CI -0.02%至0.03%;P=0.84)。
  • 9项低价值服务人均支出变化无统计学显著差异(0.33美元;95%CI -3.43至4.11美元)。

证据类型、等级与局限

  • 证据类型:质量改进研究(双重差分分析)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,全州临床医生主导倡议与低价值照护小幅减少相关且无伤害证据;实现更大降幅可能需要将健康系统驱动措施与支付改革、医生和医院问责等额外策略结合。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
  • 另有 2 条提炼内容因数值无法与原文逐一核对而未列出,请以原文为准。
英文原文(摘要)· 点击展开

IMPORTANCE: Low-value care costs more than $100 billion annually and remains pervasive despite decades of evidence documenting its clinical and financial harms. While several US states have begun discouraging its use, the feasibility of such statewide interventions in partnership with large health systems remains unknown.

OBJECTIVE: To investigate the effectiveness of a clinician-led, multistakeholder, statewide initiative to reduce low-value care in the Commonwealth of Virginia.

DESIGN, SETTING, AND PARTICIPANTS: This quality improvement study used a difference-in-differences analyses comparing low-value service changes among patients attributed to 6 health systems vs 12 control systems in the Commonwealth of Virginia preintervention (January 1 to December 31, 2019) vs postintervention (January 1 to December 31, 2022). Any patient eligible to receive 1 or more of the 9 measured low-value services in the 18 health systems evaluated were included. Data were analyzed between December 1, 2023, and September 1, 2026.

EXPOSURE: The intervention, Smarter Care Virginia, included health system financial support, clinician education, and quarterly peer-comparison performance scorecards.

MAIN OUTCOMES AND MEASURES: The primary outcome was the percentage of patients receiving any of 9 selected low-value services: (1-3) preoperative laboratory, imaging, and cardiac testing; (4-5) electrocardiogram/cardiac screening and cardiac stress testing; (6-7) diagnostic imaging and opioids for acute back pain; (8) advanced diagnostic eye imaging; and (9) peripherally inserted central catheter lines for patients with chronic kidney disease. Secondary outcomes included adverse events (eg, myocardial infarction-related hospitalization) and per-capita spending on the 9 low-value services.

RESULTS: A total of 17 223 clinicians (7222 in the intervention group and 10 001 in the control group) and 4.5 million patients (approximately 68% of Virginia's adult population) were identified. In 2019, 10.5% of patients in the intervention group and 10.7% of patients in the control group received 1 or more low-value services; in 2021 to 2022, rates declined to 8.5% and 9.1%, respectively. The intervention was associated with 10.4% fewer patients receiving 1 or more low-value services (absolute reduction, -1.1 percentage points; 95% CI, -2.1 to -0.1 percentage points; P = .04). There was no statistically significant change in adverse events (0.03%; 95% CI, -0.02% to 0.03%; P = .84) or spending on the 9 low-value services ($0.33; 95% CI, -$3.43 to $4.11).

CONCLUSIONS AND RELEVANCE: In this quality improvement study, a statewide, clinician-led initiative was associated with a small but statistically significant reduction in low-value care delivery without evidence of harm. Achieving larger reductions may require combining such health system-driven efforts with additional strategies, such as payment reform and physician and hospital accountability, that discourage the use of low-value care.

来源:JAMA Intern Med,查看原文。版权归原作者所有。

参考来源

  1. Mafi JN, Bortz BA, Vangala S, et al. Reducing Low-Value Care Through the Smarter Care Virginia Initiative. JAMA Intern Med. 2026. PMID: 43002436. doi:10.1001/jamainternmed.2026.5540

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。